The Molecular Diagnostics Market is expanding as healthcare providers increasingly seek faster and more precise methods for identifying diseases at the molecular level. Molecular diagnostic technologies analyze genetic material and biomarkers to support the detection of infectious diseases, cancer, genetic disorders, and other medical conditions. According to MRFR analysis, the market was valued at USD 17.8 billion in 2024 and is projected to reach USD 28.65 billion by 2035, growing at a CAGR of 4.42% from 2025 to 2035.

Growing demand for early diagnosis, personalized medicine, and advanced genomic technologies is supporting Market Growth. PCR, next-generation sequencing, microarrays, and in situ hybridization are among the important technologies shaping the industry. Increasing automation and the development of accessible molecular testing platforms are also creating new opportunities.

FAQ: What is molecular diagnostics?
Molecular diagnostics uses biological molecules such as DNA and RNA to identify diseases and genetic characteristics.

FAQ: What is driving the market?
Increasing disease prevalence, technological advancements, personalized healthcare, and demand for early diagnosis are key factors.